Evidence map›Paper›PMID 23108145›Full record

ArticleCancer research2013

Genome-wide association study reveals novel genetic determinants of DNA repair capacity in lung cancer.

Li-E Wang, Olga Y Gorlova, Jun Ying, Yawei Qiao, Shih-Feng Weng, Annette T Lee, Peter K Gregersen, Margaret R Spitz, Christopher I Amos, Qingyi Wei

Abstract read
In one paragraph

Article in Cancer research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. From COPD to Lung Cancer: Mechanisms Linking, Diagnosis, Treatment, and Prognosis.International journal of chronic obstructive pulmonary disease · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. DNA repair capacity correlates with standardized uptake values fromChronic diseases and translational medicine · 2018
    Article
  15. Through the Looking Glass:Applied in vitro toxicology · 2018
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Li-E WangDepartment of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Olga Y Gorlova
Jun Ying
Yawei Qiao
Shih-Feng Weng
Annette T Lee
Peter K Gregersen
Margaret R Spitz
Christopher I Amos
Qingyi Wei

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Transdisciplinary Research in Cancer of the Lung (TRICL)U19CA148127 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI AMOS, CHRISTOPHER I., LE MARCHAND, LOIC · 2010 to 2014
$10.9M
Molecular Epidemiology of Head and Neck CancerR01ES011740 · NIEHS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WEI, QINGYI · 2001 to 2012
$6.3M
ECOGENETIC STUDY OF LUNG CANCER IN MINORITIESR01CA055769 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SPITZ, MARGARET R · 1991 to 2008
$5.3M
A genomewide study of lung cancer in never smokersR01CA149462 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI GORLOVA, OLGA · 2010 to 2014
$4.4M
Inflammation Genes and Lung Cancer RiskR01CA127219 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SPITZ, MARGARET R · 2008 to 2013
$3.1M
High Density Association Analysis of Lung CancerR01CA121197 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI AMOS, CHRISTOPHER I. · 2007 to 2010
$3.0M
Genotypes and Phenotypes of Apoptosis and Risk of Head and Neck CancerR01CA131274 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WEI, QINGYI · 2009 to 2013
$3.0M
IN VITRO-INDUCED BPDE ADDUCTS AND RISK OF LUNG CANCERR01CA074851 · NCI · UNIVERSITY OF TEXAS MD ANDERSON CAN CTR · PI WEI, QINGYI · 1997 to 1999
–
NCI NIH HHS P30 CA016672NCI NIH HHS P30CA016672NCI NIH HHS R01 CA055769NCI NIH HHS R01CA055769NCI NIH HHS R01 CA074851NCI NIH HHS R01 CA121197NCI NIH HHS R01CA121197NCI NIH HHS R01 CA127219NCI NIH HHS R01CA127219NCI NIH HHS R01 CA131274NCI NIH HHS R01CA131274NCI NIH HHS R01 CA149462NCI NIH HHS R01CA149462NCI NIH HHS U19 CA148127NCI NIH HHS U19CA148127NIEHS NIH HHS R01 ES011740NIEHS NIH HHS R01ES011740
6 · The paper itself

Abstract

Suboptimal cellular DNA repair capacity (DRC) has been shown to be associated with enhanced cancer risk, but genetic variants affecting the DRC phenotype have not been comprehensively investigated. In this study, with the available DRC phenotype data, we analyzed correlations between the DRC phenotype and genotypes detected by the Illumina 317K platform in 1,774 individuals of European ancestry from a Texas lung cancer genome-wide association study. The discovery phase was followed by a replication in an independent set of 1,374 cases and controls of European ancestry. We applied a generalized linear model with single nucleotide polymorphisms as predictors and DRC (a continuous variable) as the outcome. Covariates of age, sex, pack-years of smoking, DRC assay-related variables, and case-control status of the study participants were adjusted in the model. We validated that reduced DRC was associated with an increased risk of lung cancer in both independent datasets. Several suggestive loci that contributed to the DRC phenotype were defined in ERCC2/XPD, PHACTR2, and DUSP1. In summary, we determined that DRC is an independent risk factor for lung cancer, and we defined several genetic loci contributing to DRC phenotype.

Indexed as

AdultAgedAged, 80 and overDNA RepairFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyGenotypeHumansLung NeoplasmsMaleMiddle AgedPhenotypePolymorphism, Single NucleotideRisk Factors

Identifiers

PMID23108145
PMCPMC3537906

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.